We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our
Cookie Policy
.
Accept
Label
Search
SKIP TO CONTENT
SKIP NAVIGATION
Drug News
Trending
Commercial Operations
GMPs
FDA Enforcement Actions
Inspections and Audits
Postmarket Safety
Quality
Regulatory Affairs
Research and Development
Submissions and Approvals
FDAnews Drug Weekly
FDAnews
Device News
Trending
Commercial Operations
FDA Enforcement Actions
Inspections and Audits
Postmarket Safety
Quality
Regulatory Affairs
Research and Development
Submissions and Approvals
FDAnews Device Weekly
FDAnews
Books
FDAnews Books Library
Drug Books
Device Books
Training/Events
Webinar Training Pass
Events
Webinar Recordings
Resources
Form 483s Database
FDA Approved Drugs
White Papers
CenterWatch
About Us
The Company
FDAnews Editorial Board
Contact Us
Advertising
Sign In
Create Account
Sign Out
My Account
Home
» Australia Hikes GMP Clearance Fees
Australia Hikes GMP Clearance Fees
June 4, 2019
Drugs
Regulatory Affairs
Drugmakers in Australia will soon be subject to higher GMP clearance fees, the Therapeutic Goods Administration (TGA) announced.
To View This Article:
Login
Email
Password
Register
Remember Me
Forgot your password?
Subscribe To Drug GMP Report
Buy This Article Now
Add this article to your cart for $40.00
Upcoming Events
11
Oct
GMP Quality Management vSummit 2023: Where Quality Meets Risk
16
Oct
MAGI@home Clinical Research Conference 2023
26
Oct
FDA in 2024: What to Expect in an Election Year
02
Nov
How UDI and UDI Data Can — and Must — Be Used for More Than Just Device Identification
08
Nov
18th Annual FDA Inspections vSummit
Featured Products
FDA, FTC and DOJ Enforcement of Medical Device Regulations
Using Real-World Evidence in Drug and Device Submissions
Featured Stories
Potential Penalties Force BMS to Sign Drug Price Negotiation Agreement With CMS
Despite AdComm Endorsement, neffy Nasal Spray Alternate for EpiPen Gets CRL
Adcomm Votes Down ALS Stem Cell Therapy, Debates Clinical Data vs. Personal Data
Reports Allege Philips Withheld Evidence of Ventilator Malfunctions for 11 Years
The Revised ICH E8:
A Guide to New Clinical Trial Requirements
Learn More
